Introduction: Cancers that are known collectively as head and neck cancers can vary in their histological form and localization. This disease has a high social significance thus it require well-timed and delicate approach, especially in children. We can improve the accuracy of our methods by using new algorithms and technologies. We were the first to implement 99mTc-MIBI SPECT/CT imaging in evaluation of children with head and neck cancer and introduce it as a routine method in Russia. Purpose: Improve the accuracy in diagnostics of children with head and neck cancer by practical application of hybrid SPECT/CT method. To determine diagnostic value of planar scintigraphy and 99mTc-MIBI SPECT/CT in children with head and neck cancer. Material and methods: This study was performed as a prospective clinical study. Between January 2017 and December 2017, 53 patients which met the inclusion criteria were examined. The inclusion criteria were patients with histologically proven malignancy, age 1–18, weight more than 10 kg, up to date CT or MRI scans (less than two weeks passed from scanning), for initial patients a tumor findings (more than 20 mm in the largest scale). We concluded 61 whole body planar scintigraphy followed by head and neck 99mTc-MIBI SPECT/CT examinations. 10 patients were examined twice, 1patient was undergoing for this procedure for three times. Initial patients – 23, dynamic – 30. We performed scanning using a hybrid SPECT/CT after 15 minutes 99mTc-MIBI was injected. First stage was standard whole-body planar scintigraphy, second stage SPECT/CT (head and neck). Results: We evaluated diagnostic accuracy of planar scintigraphy and 99mTc-MIBI SPECT/CT. Planar scintigraphy sensitivity, specificity, NPV and PPV were 68.8, 96.6, 73.7, 95.7 %. SPECT/CT – 87.5, 96.6, 87.5, 96.6 %. The verification method was histological examination or follow-up imagining (CT or MRI) during a 12 month period. Additional imagining using hybrid SPECT/CT method allows us to increase sensitivity and NPV of isotope scanning. Most of false-negative results were obtained after planar scintigraphy, it can be related with image interpretation difficulties caused by equivocal image, especially, in patients during therapy. Six of such patients were correctly diagnosed with SPECT/CT and we revealed the presence of active tumor tissue. With CT we additionally detected destruction of skull bones in 10 patients. Conclusion: 1. Diagnostic accuracy of scintigraphy with 99mTc-MIBI is high: Sens. – 68.8 %. 2. We can increase diagnostic accuracy using hybrid methods, and so it plays an important role in final diagnosis: Sens. – 87.5 %, Spec. – 96.6 %. 3. SPECT/CT additionally detected destruction of skull bones even with negative scintigraphy results. 4. A strict clinical reasoning is needed in each individual case. 5. A further evaluation of the diagnostic capabilities of 99mTc-MIBI SPECT/CT in a larger number of patients appears justified.
3ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России; Россия, 127473 Москва, ул. Делегатская, 20, стр. 1; 4 ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации; Россия, 121359 Москва, ул. Маршала Тимошенко, 19, стр Введение Паращитовидные железы (ПЩЖ) представлены 2 парами мелких желез массой около 0,05 г и диаме-тром 4-6 мм каждая. Это удлиненные или округлые образования, которые располагаются на задней сто-роне боковых долей щитовидной железы, прилегая к ее собственной капсуле. Они, как и щитовидная железа, покрыты общей с ней фиброзной капсулой.
ЯдернаЯ медицинаЭффективность методов радионуклидной визуализации сторожевого лимфоузла у пациентов с меланомой кожи л.Ю. абдулова 1 , а.с. крылов 1 , а.д. рыжков 1,2 , е.а. николаева 1 , т.в. захарова 1 , м.е. Билик 1 , к.а. Барышников 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.